Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2026-01-23 @ 2:57 PM
Study NCT ID:
NCT00520468
Status:
COMPLETED
Last Update Posted:
2012-08-07
First Post:
2007-08-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myelodysplastic Syndrome | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Myelodysplastic Syndrome | View |
| None | MDS | View |
| None | Erythropoietin | View |
| None | Darbepoetin alfa | View |
| None | Aranesp | View |
| None | Erythropoiesis stimulating protein | View |
| None | G-CSF | View |
| None | Filgrastim | View |
| None | Neupogen | View |
| None | Prednisone | View |
| None | Cyclosporin A | View |
| None | Sandimmune | View |
| None | CYA | View |
| None | Cyclosporine | View |